Advertisement

Topics

GSK grabs Calico top scientist and Roche veteran as new R&D head

06:28 EST 8 Nov 2017 | Reuters

LONDON (Reuters) - GlaxoSmithKline has poached veteran drug industry scientist Hal Barron from Alphabet-funded Calico as its new research head, showing new Chief Executive Emma Walmsley's determination to improve productivity.

Original Article: GSK grabs Calico top scientist and Roche veteran as new R&D head

NEXT ARTICLE

More From BioPortfolio on "GSK grabs Calico top scientist and Roche veteran as new R&D head"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

GlaxoSmithKline
GlaxoSmithKline is the third largest pharmaceutical company in the world, based on annual sales, which reached $37,134m in 2009. Spread over 100 countries, GSK employs 96,500 people, 13,000 of which are dedicated to research and development of the the ...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...